Physiologically active substances
US7893068B2 · kind B2 · utility
0Cited by
8References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 29, 2007 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Aug 26, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D407/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound represented by the formula (I):(wherein, R3, R6, R7 and R21 are the same as or different from one another and each represents a hydroxyl group etc.), a pharmacologically acceptable salt thereof or a hydrate of them. The compound (I) of the present invention suppresses angiogenesis, in particular, suppresses VEGF production in a hypoxic condition and is useful as a therapeutic agent for treating solid cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.